Torrent Pharma, Zydus Lifescinces ink pact to co-market Saroglitazar Mg for chronic liver diseases in India Ruchika Sharma11 Nov 2023 2:15 PM ISTSaroglitazar Mg, is an innovative drug from Zydus approved by the DCGI to treat chronic liver diseases such as, Non-Alcoholic Steato Hepatitis (NASH)...
Zydus Lifesciences, Lupin to co-market Saroglitazar Mg for chronic liver diseases treatment in India Ruchika Sharma3 Nov 2023 3:30 PM ISTUnder the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS.
Researchers Create Highly Accurate Non-Invasive Test for Major Liver Diseases Dr. Kamal Kant Kohli16 July 2022 12:30 AM ISTResearchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly...
Semaglutide shows promise in patients with nonalcoholic steatohepatitis: NEJM Dr Satabdi Saha18 Nov 2020 6:00 PM ISTAccording to the findings of a recently published study in New England Journal of Medicine, treatment with semaglutide resulted in a significantly...
Zydus to present PBC, NASH clinical trial data of Saroglitazar Mg Ruchika Sharma3 Nov 2020 1:00 PM ISTAhmedabad: Zydus, a discovery based, global pharmaceutical company, has recently announced that a Late-Breaker Oral Presentation and two Poster...
